title: Genetics and genomics of prostate cancer.
abstract: Prostate cancer (PCa) is one of the most common malignancies in the world with over 890 000 cases and over 258 000 deaths worldwide each year. Nearly all mortalities from PCa are due to metastatic disease, typically through tumors that evolve to be hormone-refractory or castrate-resistant. Despite intensive epidemiological study, there are few known environmental risk factors, and age and family history are the major determinants. However, there is extreme heterogeneity in PCa incidence worldwide, suggesting that major determining factors have not been described. Genome-wide association studies have been performed and a considerable number of significant, but low-risk loci have been identified. In addition, several groups have analyzed PCa by determination of genomic copy number, fusion gene generation and targeted resequencing of candidate genes, as well as exome and whole genome sequencing. These initial studies have examined both primary and metastatic tumors as well as murine xenografts and identified somatic alterations in TP53 and other potential driver genes, and the disturbance of androgen response and cell cycle pathways. It is hoped that continued characterization of risk factors as well as gene mutation and misregulation in tumors will aid in understanding, diagnosing and better treating PCa.
authors.affiliation: Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA. deanm@mail.nih.gov
authors.forename: Michael
authors.initials: M
authors.lastname: Dean
authors.forename: Hong
authors.initials: H
authors.lastname: Lou
mesh_terms: D016678:Genome; D055106:Genome-Wide Association Study; D006801:Humans; D008297:Male; D009154:Mutation; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000235:genetics*; D044469:Racial Groups / Q000235:genetics*; D012307:Risk Factors
references.citation: Nat Genet. 2008 Mar;40(3):310-5
references.pmid: 18264096
references.citation: DNA Repair (Amst). 2012 Aug 1;11(8):693-701
references.pmid: 22677538
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53
references.pmid: 22714738
references.citation: Nat Genet. 2008 Mar;40(3):316-21
references.pmid: 18264097
references.citation: Prostate. 2011 Apr;71(5):489-97
references.pmid: 20878952
references.citation: Int J Cancer. 1998 Oct 29;78(3):293-7
references.pmid: 9766560
references.citation: N Engl J Med. 2012 Jan 12;366(2):141-9
references.pmid: 22236224
references.citation: Nat Genet. 2009 Oct;41(10):1122-6
references.pmid: 19767754
references.citation: Prostate. 2010 Jul 1;70(10):1146-52
references.pmid: 20333697
references.citation: J Med Genet. 2003 Oct;40(10):787-92
references.pmid: 14569130
references.citation: Hum Mutat. 2013 Jan;34(1):149-56
references.pmid: 22887727
references.citation: Oncogene. 2005 May 26;24(23):3847-52
references.pmid: 15750627
references.citation: Asian J Androl. 2009 Jan;11(1):49-55
references.pmid: 19050691
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3001-5
references.pmid: 20133699
references.citation: Cancer. 2003 Apr 15;97(8):1894-903
references.pmid: 12673715
references.citation: Nat Genet. 2011 Aug 07;43(9):828-9
references.pmid: 21822264
references.citation: Mol Cell. 2009 Oct 9;36(1):39-50
references.pmid: 19818708
references.citation: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9742-6
references.pmid: 20453196
references.citation: Prostate. 1990;17(4):337-47
references.pmid: 2251225
references.citation: Clin Cancer Res. 2011 Mar 1;17(5):1075-81
references.pmid: 21343373
references.citation: Proc Natl Acad Sci U S A. 2009 May 12;106(19):7933-8
references.pmid: 19383797
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Clin Cancer Res. 2010 Apr 1;16(7):2115-21
references.pmid: 20215531
references.citation: Oncologist. 2007 Jan;12(1):20-37
references.pmid: 17227898
references.citation: Nat Genet. 2007 May;39(5):645-9
references.pmid: 17401363
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17087-92
references.pmid: 21949389
references.citation: Nat Rev Urol. 2009 Aug;6(8):429-39
references.pmid: 19657377
references.citation: Nat Rev Urol. 2012 Feb 14;9(3):131-7
references.pmid: 22331093
references.citation: Prostate. 2003 Dec 1;57(4):261-9
references.pmid: 14601022
references.citation: Science. 2011 Oct 14;334(6053):252-5
references.pmid: 21868628
references.citation: Hum Mutat. 2012 Jan;33(1):100-3
references.pmid: 22009941
references.citation: Eur J Cancer. 2005 Apr;41(6):834-45
references.pmid: 15808953
references.citation: Epidemiol Rev. 2001;23(1):19-23
references.pmid: 11588848
references.citation: Hum Mol Genet. 2009 Apr 1;18(7):1368-75
references.pmid: 19153072
references.citation: Nature. 2012 Jul 12;487(7406):239-43
references.pmid: 22722839
references.citation: Nat Genet. 2009 Oct;41(10):1055-7
references.pmid: 19767755
references.citation: Hum Mol Genet. 2012 May 1;21(9):2076-85
references.pmid: 22323358
references.citation: Cell Res. 2012 May;22(5):806-21
references.pmid: 22349460
references.citation: Urology. 2012 Oct;80(4):749-53
references.pmid: 22950997
references.citation: Nature. 2011 Feb 10;470(7333):214-20
references.pmid: 21307934
references.citation: Br J Cancer. 1991 Jun;63(6):963-6
references.pmid: 2069852
references.citation: Mol Endocrinol. 2003 Aug;17(8):1484-507
references.pmid: 12750453
references.citation: J Natl Cancer Inst. 1968 Jan;40(1):43-68
references.pmid: 5635018
references.citation: Clin Cancer Res. 2004 May 1;10(9):2918-21
references.pmid: 15131025
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2639-46
references.pmid: 20736317
references.citation: Science. 2005 Oct 28;310(5748):644-8
references.pmid: 16254181
references.citation: Hum Genet. 2012 Sep;131(9):1453-1466
references.pmid: 22661295
references.citation: Nat Genet. 2004 Sep;36(9):979-83
references.pmid: 15300251
references.citation: Hum Mol Genet. 2011 Oct 1;20(19):3867-75
references.pmid: 21743057
references.citation: Hum Mutat. 2005 Sep;26(3):214-23
references.pmid: 16086313
references.citation: Nat Genet. 2009 Oct;41(10):1116-21
references.pmid: 19767753
references.citation: Hum Genet. 2009 Dec;126(6):743-50
references.pmid: 19644707
references.citation: Cancer Res. 2010 Jul 1;70(13):5207-12
references.pmid: 20516122
references.citation: Nat Genet. 2011 Aug 07;43(9):875-8
references.pmid: 21822268
references.citation: Nat Genet. 2012 May 20;44(6):685-9
references.pmid: 22610119
references.citation: PLoS One. 2010 Oct 13;5(10):e13363
references.pmid: 20967219
references.citation: Nat Genet. 2012 Dec;44(12):1326-9
references.pmid: 23104005